Nitrofurantoin-induced chronic active hepatitis.

Author(s): Amit G, Cohen P, Ackerman Z

Affiliation(s): Department of Medicine, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel.

Publication date & source: 2002-03, Isr Med Assoc J., 4(3):184-6.

Publication type: Case Reports; Review

BACKGROUND: Nitrofurantoin is a commonly prescribed urinary antiseptic. Hepatic injury has been associated with its use. OBJECTIVES: To present three patients in whom long-term exposure to the drug resulted in chronic active hepatitis; and to review the epidemiology, clinical immunology, histopathology, pathogenetic features and treatment of previously reported cases. RESULTS: Withdrawing nitrofurantoin once the diagnosis was suspected did not lead to remission of the liver disease and glucocorticoids had to be administered. One patient died of liver failure. CONCLUSIONS: Awareness of this unusual side effect of nitrofurantoin is important and caution should be taken before prescribing it. Over the past years new insight into the immune nature of this drug has emerged.